Literature DB >> 25993975

Middle East respiratory syndrome coronavirus infection not found in camels in Japan.

Kazuya Shirato1, Akinori Azumano, Tatsuko Nakao, Daisuke Hagihara, Manabu Ishida, Kanji Tamai, Kouji Yamazaki, Miyuki Kawase, Yoshiharu Okamoto, Shigehisa Kawakami, Naonori Okada, Kazuko Fukushima, Kensuke Nakajima, Shutoku Matsuyama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25993975     DOI： 10.7883/yoken.JJID.2015.094

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN： 1344-6304            Impact factor:   1.362


× No keyword cloud information.
  9 in total

Review 1.  MERS coronavirus: diagnostics, epidemiology and transmission.

Authors:  Ian M Mackay; Katherine E Arden
Journal:  Virol J       Date:  2015-12-22       Impact factor: 4.099

Review 2.  Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction.

Authors:  Ali S Omrani; Jaffar A Al-Tawfiq; Ziad A Memish
Journal:  Pathog Glob Health       Date:  2015       Impact factor: 2.894

3.  Global status of Middle East respiratory syndrome coronavirus in dromedary camels: a systematic review.

Authors:  R S Sikkema; E A B A Farag; Mazharul Islam; Muzzamil Atta; C B E M Reusken; Mohd M Al-Hajri; M P G Koopmans
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

4.  A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: Implications for animal vaccination.

Authors:  Amy Dighe; Thibaut Jombart; Maria D Van Kerkhove; Neil Ferguson
Journal:  Epidemics       Date:  2019-06-05       Impact factor: 4.396

5.  Evaluation of serological assays available in a biosafety level 2 laboratory and their application for survey of Middle East respiratory syndrome coronavirus among livestock in Ethiopia.

Authors:  Takurou Teramichi; Shuetsu Fukushi; Yuma Hachiya; Simenew Keskes Melaku; Keisuke Oguma; Hiroshi Sentsui
Journal:  J Vet Med Sci       Date:  2019-11-05       Impact factor: 1.267

Review 6.  MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges.

Authors:  Ali A Rabaan; Shamsah H Al-Ahmed; Ranjit Sah; Mohammed A Alqumber; Shafiul Haque; Shailesh Kumar Patel; Mamta Pathak; Ruchi Tiwari; Mohd Iqbal Yatoo; Abrar Ul Haq; Muhammad Bilal; Kuldeep Dhama; Alfonso J Rodriguez-Morales
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-01-18       Impact factor: 3.944

7.  Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice.

Authors:  Hirofumi Kato; Mutsuyo Takayama-Ito; Itoe Iizuka-Shiota; Shuetsu Fukushi; Guillermo Posadas-Herrera; Madoka Horiya; Masaaki Satoh; Tomoki Yoshikawa; Souichi Yamada; Shizuko Harada; Hikaru Fujii; Miho Shibamura; Takuya Inagaki; Kinjiro Morimoto; Masayuki Saijo; Chang-Kweng Lim
Journal:  PLoS One       Date:  2019-10-07       Impact factor: 3.240

8.  Characterization of novel monoclonal antibodies against the MERS-coronavirus spike protein and their application in species-independent antibody detection by competitive ELISA.

Authors:  Shuetsu Fukushi; Aiko Fukuma; Takeshi Kurosu; Shumpei Watanabe; Masayuki Shimojima; Kazuya Shirato; Naoko Iwata-Yoshikawa; Noriyo Nagata; Kazuo Ohnishi; Manabu Ato; Simenew Keskes Melaku; Hiroshi Sentsui; Masayuki Saijo
Journal:  J Virol Methods       Date:  2017-10-06       Impact factor: 2.014

9.  Middle East Respiratory Syndrome Coronavirus Antibodies in Bactrian and Hybrid Camels from Dubai.

Authors:  Susanna K P Lau; Kenneth S M Li; Hayes K H Luk; Zirong He; Jade L L Teng; Kwok-Yung Yuen; Ulrich Wernery; Patrick C Y Woo
Journal:  mSphere       Date:  2020-01-22       Impact factor: 4.389
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.